Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
A phase II study of axitinib in advanced neuroendocrine tumors. [electronic resource] by
- Strosberg, J R
- Cives, M
- Hwang, J
- Weber, T
- Nickerson, M
- Atreya, C E
- Venook, A
- Kelley, R K
- Valone, T
- Morse, B
- Coppola, D
- Bergsland, E K
Producer: 20180112
In:
Endocrine-related cancer vol. 23
Availability: No items available.
|
|
8.
|
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. [electronic resource] by
- Ducker, G S
- Atreya, C E
- Simko, J P
- Hom, Y K
- Matli, M R
- Benes, C H
- Hann, B
- Nakakura, E K
- Bergsland, E K
- Donner, D B
- Settleman, J
- Shokat, K M
- Warren, R S
Producer: 20140507
In:
Oncogene vol. 33
Availability: No items available.
|
|
9.
|
A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. [electronic resource] by
- Kelley, R K
- Hwang, J
- Magbanua, M J M
- Watt, L
- Beumer, J H
- Christner, S M
- Baruchel, S
- Wu, B
- Fong, L
- Yeh, B M
- Moore, A P
- Ko, A H
- Korn, W M
- Rajpal, S
- Park, J W
- Tempero, M A
- Venook, A P
- Bergsland, E K
Producer: 20131204
In:
British journal of cancer vol. 109
Availability: No items available.
|
|
10.
|
Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. [electronic resource] by
- Kelley, R K
- Nimeiri, H S
- Munster, P N
- Vergo, M T
- Huang, Y
- Li, C-M
- Hwang, J
- Mulcahy, M F
- Yeh, B M
- Kuhn, P
- Luttgen, M S
- Grabowsky, J A
- Stucky-Marshall, L
- Korn, W M
- Ko, A H
- Bergsland, E K
- Benson, A B
- Venook, A P
Producer: 20131211
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|